“…Doctors in Britain followed events across the Atlantic very closely (Editorial 1949c). In January 1950, John McNee, Regius Professor of Medicine at the University of Glasgow, reported on his recent 3-month stay and was obviously affected by the new mood, claiming that ‘something quite new and fundamental in medicine and therapeutics had been discovered, with far wider possibilities and implications far beyond the boundaries of the chronic rheumatic diseases’ (McNee 1950, p. 114). The other diseases he listed were: ‘acute rheumatic fever, chorea, gout, chronic ulcerative colitis, lupus erythematosus diffusa, scleroderma (with oesophageal involvement), asthma, lymphadenopathies (including lymphosarcoma and Hodgkin’s disease).’ On ‘compound E’ and ACTH, McNee reiterated the now familiar accounts of ‘rapid and intensely dramatic effects’ in patients with RA, observing that though the drug’s effects were like turning a tap on and off, many courses of treatment led to ‘lasting improvement over a number of months.’ However, there were side effects to consider.…”